Kirkland, Goodwin Steer Lilly's $7.8B 'Sleep-Wake' Disorder Deal
Pharmaceutical giant Eli Lilly & Co., advised by Kirkland & Ellis LLP, on Tuesday announced plans to acquire daytime sleepiness-focused pharmaceutical company Centessa Pharmaceuticals PLC, led by Goodwin Procter LLP, in...To view the full article, register now.
Already a subscriber? Click here to view full article